Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)

7,895 views 18 slides Apr 08, 2020
Slide 1
Slide 1 of 18
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18

About This Presentation

Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)
Concept of pharmacophore, Pharmacophore mapping, Identification of pharmacophore features and pharmacophore modeling, Conformation search used in pharmacophore mapping, Virtual screening.


Slide Content

PHARMACOPHORE MAPPING AND VIRTUAL SCREENING Presented by- Mr . Akshay Ramchandra Yadav ( First year M.pharm ) . Pharmaceutical chemistry Dept. Rajarambapu C ollege of P harmacy, K asegaon .

CONTENTS Concept of pharmacophore Pharmacophore mapping Identification of pharmacophore features and pharmacophore modeling Conformation search used in pharmacophore mapping Virtual screening

IUPAC defines a  pharmacophore  to be "an ensemble of steric and electronic features that is necessary to ensure the optimal supramolecular interactions with a specific biological target and to trigger (or block) its biological response". With pharmacophoric models one can define special properties ( pharmacophoric points) based on the structure of the receptor or based on the structure of a known agent. MolSign is a complete module for pharmacophore identification and modeling. Identification of the pharmacophoric features such as H-bond donor, H-bond acceptor, positive charge, negative charge and hydrophobe facilitate the complete pharmacophoric mapping of the molecule. PHARMACOPHORE

EXAMPLE- An example of a pharmacophore model of the  benzodiazepine  binding site on the  GABA A receptor .  White sticks represent the carbon atoms of the benzodiazepine   diazepam, while green represents carbon atoms of the nonbenzodiazepine   CGS-9896.. Red and blue sticks are oxygen and nitrogen atoms that are present in both structures.

PHARMACOPHORE MAPPING The goal of Pharmacophore mapping is to establish the bioactive conformations of the Ligand and how to superimpose the mapping, one needs structure-activity relationships of structurally diverse and conformation informative molecules .

Software use for Pharmacophore mapping: Disco Hip-hop Aladdin Apex Gasp Accelary Apollo Rapid 21

Application: Application of Pharmacophore mapping is used to understand the biological activity observed in series of compounds. So that we can design new and more potent compound.

IDENTIFICATION OF PHARMACOPHORE FEATURES TYPICAL FEATURES Hydrophobic Aromatic H-bond acceptor H-bond donor Cationic or Anionic moieties

PHARMACOPHORE MODELLING A pharmacophore model consists of a few features organized in a specific 3D pattern. 50 The features can be labeled as a single feature or any logic combination consisting of “AND,” “OR,” and “NOT” to combine different interaction patterns within one label. Each of these conformations is fitted to the pharmacophore query by aligning the pharmacophore features of the molecule and the query is composed. If a molecule can be fitted inside the spheres representing the query features it is considered a hit molecule.

Depending on how much is known about the particular protein target, different options are available to construct such a query. Four different situations for the pharmacophore search .

Limitations of pharmacophore methods The major limitation in virtual screening by pharmacophore is the absence of good scoring metrics. A second limitation is the dependency of a pharmacophore -based virtual screen on a pre-computed conformation database. These databases only contain a limited number of low-energy conformations per molecule.

CONFORMATIONAL SEARCH USED IN PHARMACOPHORE MAPPING Conformation generally means structural arrangement. Conformations are different three dimensional structure of molecules that arises from. -rotations about single bonds (torsional angles). -different rings conformations. The biological activity of molecules is strongly dependent on their conformations. Done by exploring the energy surface of a molecule and determining the conformation with minimal energy, Conformational analysis is needed to identify the ideal conformation of the molecule.

Different methods the conformations search can be quite large and can be approaches using following methods 1.Systemic search method 2.Distance geometry method 3.Clique detection alogorithm

Virtual screening ( VS ) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target , typically a protein receptor or enzyme . Pharmacophore -based virtual screening is nowadays a mature technology, very well accepted in the medicinal chemistry laboratory . l ike any empirical approach, it has specific limitations and efforts to improve the methodology are still ongoing . VIRTUAL SCREENING

Methods There are two broad categories of screening techniques: ligand-based and structure-based .

Ligand-based - Given a set of structurally diverse ligands that binds to a receptor, a model of the receptor can be built by exploiting the collective information contained in such set of ligands. These are known as pharmacophore models . Structure-based- Structure-based virtual screening involves docking of candidate ligands into a protein target followed by applying a scoring function to estimate the likelihood that the ligand will bind to the protein with high affinity .

References- Rester U (July 2008). "From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective". Current Opinion in Drug Discovery & Development. 11 (4): 559–68. PMID 18600572 . Rollinger JM, Stuppner H, Langer T (2008). Virtual screening for the discovery of bioactive natural products. Progress in Drug Research . Fortschritte der Arzneimittelforschung . Progres des Recherches Pharmaceutiques . Progress in Drug Research. 65 . pp. 211, 213–49. Walters WP, Stahl MT, Murcko MA (1998). "Virtual screening – an overview". Drug Discov . Today. 3 (4): 160–178.
Tags